File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: International network of cancer genome projects

TitleInternational network of cancer genome projects
Authors
Hudson, Thomas J.Anderson, WarwickAretz, AxelBarker, Anna D.Bell, CindyBernabé, Rosa R.Bhan, M. K.Calvo, FabienEerola, IiroGerhard, Daniela S.Guttmacher, AlanGuyer, MarkHemsley, Fiona M.Jennings, Jennifer L.Kerr, DavidKlatt, PeterKolar, PatrikKusuda, JunLane, David P.Laplace, FrankLu, YouyongNettekoven, GerdOzenberger, BradPeterson, JaneRao, T. S.Remacle, JacquesSchafer, Alan J.Shibata, TatsuhiroStratton, Michael R.Vockley, Joseph G.Watanabe, KoichiYang, HuanmingYuen, Matthew M.F.Knoppers, Bartha M.Bobrow, MartinCambon-Thomsen, AnneDressler, Lynn G.Dyke, Stephanie O.M.Joly, YannKato, KazutoKennedy, Karen L.Nicolás, PilarParker, Michael J.Rial-Sebbag, EmmanuelleRomeo-Casabona, Carlos M.Shaw, Kenna M.Wallace, SusanWiesner, Georgia L.Zeps, NikolajsLichter, PeterBiankin, Andrew V.Chabannon, ChristianChin, LyndaClément, BrunoAlava, Enrique DeDegos, FrançoiseFerguson, Martin L.Geary, PeterHayes, D. NeilJohns, Amber L.Kasprzyk, ArekNakagawa, HidewakiPenny, RobertPiris, Miguel A.Sarin, RajivScarpa, AldoDe Vijver, Marc VanFutreal, P. AndrewAburatani, HiroyukiBayés, MónicaBowtell, David D.L.Campbel, Peter J.Estivill, XavierGrimmond, Sean M.Gut, IvoHirst, MartinLópez-Otý́n, CarlosMajumder, ParthaMarra, MarcoMcPherson, John D.Ning, ZeminPuente, Xose S.Ruan, YijunStunnenberg, Hendrik G.Swerdlow, HaroldVelculescu, Victor E.
Issue Date2010
Citation
Nature, 2010, v. 464, n. 7291, p. 993-998 How to Cite?
DOI: http://dx.doi.org/10.1038/nature08987
AbstractThe International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies. © 2010 Macmillan Publishers Limited. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/250937
ISSN
0028-0836
2023 Impact Factor: 50.5
2023 SCImago Journal Rankings: 18.509
ISI Accession Number ID
WOS:000276635000029

 

DC FieldValueLanguage
dc.contributor.authorHudson, Thomas J.-
dc.contributor.authorAnderson, Warwick-
dc.contributor.authorAretz, Axel-
dc.contributor.authorBarker, Anna D.-
dc.contributor.authorBell, Cindy-
dc.contributor.authorBernabé, Rosa R.-
dc.contributor.authorBhan, M. K.-
dc.contributor.authorCalvo, Fabien-
dc.contributor.authorEerola, Iiro-
dc.contributor.authorGerhard, Daniela S.-
dc.contributor.authorGuttmacher, Alan-
dc.contributor.authorGuyer, Mark-
dc.contributor.authorHemsley, Fiona M.-
dc.contributor.authorJennings, Jennifer L.-
dc.contributor.authorKerr, David-
dc.contributor.authorKlatt, Peter-
dc.contributor.authorKolar, Patrik-
dc.contributor.authorKusuda, Jun-
dc.contributor.authorLane, David P.-
dc.contributor.authorLaplace, Frank-
dc.contributor.authorLu, Youyong-
dc.contributor.authorNettekoven, Gerd-
dc.contributor.authorOzenberger, Brad-
dc.contributor.authorPeterson, Jane-
dc.contributor.authorRao, T. S.-
dc.contributor.authorRemacle, Jacques-
dc.contributor.authorSchafer, Alan J.-
dc.contributor.authorShibata, Tatsuhiro-
dc.contributor.authorStratton, Michael R.-
dc.contributor.authorVockley, Joseph G.-
dc.contributor.authorWatanabe, Koichi-
dc.contributor.authorYang, Huanming-
dc.contributor.authorYuen, Matthew M.F.-
dc.contributor.authorKnoppers, Bartha M.-
dc.contributor.authorBobrow, Martin-
dc.contributor.authorCambon-Thomsen, Anne-
dc.contributor.authorDressler, Lynn G.-
dc.contributor.authorDyke, Stephanie O.M.-
dc.contributor.authorJoly, Yann-
dc.contributor.authorKato, Kazuto-
dc.contributor.authorKennedy, Karen L.-
dc.contributor.authorNicolás, Pilar-
dc.contributor.authorParker, Michael J.-
dc.contributor.authorRial-Sebbag, Emmanuelle-
dc.contributor.authorRomeo-Casabona, Carlos M.-
dc.contributor.authorShaw, Kenna M.-
dc.contributor.authorWallace, Susan-
dc.contributor.authorWiesner, Georgia L.-
dc.contributor.authorZeps, Nikolajs-
dc.contributor.authorLichter, Peter-
dc.contributor.authorBiankin, Andrew V.-
dc.contributor.authorChabannon, Christian-
dc.contributor.authorChin, Lynda-
dc.contributor.authorClément, Bruno-
dc.contributor.authorAlava, Enrique De-
dc.contributor.authorDegos, Françoise-
dc.contributor.authorFerguson, Martin L.-
dc.contributor.authorGeary, Peter-
dc.contributor.authorHayes, D. Neil-
dc.contributor.authorJohns, Amber L.-
dc.contributor.authorKasprzyk, Arek-
dc.contributor.authorNakagawa, Hidewaki-
dc.contributor.authorPenny, Robert-
dc.contributor.authorPiris, Miguel A.-
dc.contributor.authorSarin, Rajiv-
dc.contributor.authorScarpa, Aldo-
dc.contributor.authorDe Vijver, Marc Van-
dc.contributor.authorFutreal, P. Andrew-
dc.contributor.authorAburatani, Hiroyuki-
dc.contributor.authorBayés, Mónica-
dc.contributor.authorBowtell, David D.L.-
dc.contributor.authorCampbel, Peter J.-
dc.contributor.authorEstivill, Xavier-
dc.contributor.authorGrimmond, Sean M.-
dc.contributor.authorGut, Ivo-
dc.contributor.authorHirst, Martin-
dc.contributor.authorLópez-Otý́n, Carlos-
dc.contributor.authorMajumder, Partha-
dc.contributor.authorMarra, Marco-
dc.contributor.authorMcPherson, John D.-
dc.contributor.authorNing, Zemin-
dc.contributor.authorPuente, Xose S.-
dc.contributor.authorRuan, Yijun-
dc.contributor.authorStunnenberg, Hendrik G.-
dc.contributor.authorSwerdlow, Harold-
dc.contributor.authorVelculescu, Victor E.-
dc.date.accessioned2018-02-01T01:54:07Z-
dc.date.available2018-02-01T01:54:07Z-
dc.date.issued2010-
dc.identifier.citationNature, 2010, v. 464, n. 7291, p. 993-998-
dc.identifier.issn0028-0836-
dc.identifier.urihttp://hdl.handle.net/10722/250937-
dc.description.abstractThe International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies. © 2010 Macmillan Publishers Limited. All rights reserved.-
dc.languageeng-
dc.relation.ispartofNature-
dc.titleInternational network of cancer genome projects-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1038/nature08987-
dc.identifier.pmid20393554-
dc.identifier.scopuseid_2-s2.0-77951115122-
dc.identifier.volume464-
dc.identifier.issue7291-
dc.identifier.spage993-
dc.identifier.epage998-
dc.identifier.eissn1476-4687-
dc.identifier.isiWOS:000276635000029-
dc.identifier.issnl0028-0836-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats